Hologenix, LLC today announced the appointment of Jim Calhoun as chief executive officer. He replaces co-founder, Seth Casden in the CEO position, enabling Casden to focus on sales, science and innovation. Calhoun remains an officer on the Hologenix board of directors and was most recently president and CEO of Converse, a wholly-owned subsidiary of NIKE, Inc.
Celliant is a patented responsive textile technology that harnesses and recycles the body’s natural energy through the use of fiber. In July, Celliant received a much-coveted classification from the U.S. Food and Drug Administration (FDA) as a medical device and general wellness product. Celliant is used in more than 60 countries and across a variety of industries, including bedding, apparel, furniture and pet products.
“Jim has spent 25 years working at some of the most successful and iconic global brands in the consumer products industry,” said Bill Werlin, chairman of the board. “I speak for the entire board when I say we are thrilled to have him as CEO.”